Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Short term Debt (2016 - 2018)

Historic Short term Debt for Cardiff Oncology (CRDF) over the last 6 years, with Q1 2018 value amounting to $1.2 million.

  • Cardiff Oncology's Short term Debt fell 6966.55% to $1.2 million in Q1 2018 from the same period last year, while for Mar 2018 it was $1.2 million, marking a year-over-year decrease of 6966.55%. This contributed to the annual value of $1.3 million for FY2017, which is 4358.25% down from last year.
  • Latest data reveals that Cardiff Oncology reported Short term Debt of $1.2 million as of Q1 2018, which was down 6966.55% from $1.3 million recorded in Q4 2017.
  • Cardiff Oncology's 5-year Short term Debt high stood at $6.1 million for Q2 2016, and its period low was $200792.0 during Q1 2014.
  • Moreover, its 5-year median value for Short term Debt was $2.1 million (2014), whereas its average is $2.6 million.
  • Its Short term Debt has fluctuated over the past 5 years, first skyrocketed by 142632.28% in 2015, then plummeted by 7861.2% in 2016.
  • Quarter analysis of 5 years shows Cardiff Oncology's Short term Debt stood at $1.9 million in 2014, then skyrocketed by 175.25% to $5.2 million in 2015, then plummeted by 54.84% to $2.4 million in 2016, then plummeted by 43.58% to $1.3 million in 2017, then fell by 11.76% to $1.2 million in 2018.
  • Its Short term Debt stands at $1.2 million for Q1 2018, versus $1.3 million for Q4 2017 and $1.5 million for Q3 2017.